0000313143-14-000044.txt : 20140429
0000313143-14-000044.hdr.sgml : 20140429
20140429125855
ACCESSION NUMBER: 0000313143-14-000044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140428
FILED AS OF DATE: 20140429
DATE AS OF CHANGE: 20140429
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0330
BUSINESS ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALLEN PETER M
CENTRAL INDEX KEY: 0001261832
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 14792717
MAIL ADDRESS:
STREET 1: HAEMONETICS CORP
STREET 2: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184-9144
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-04-28
0
0000313143
HAEMONETICS CORP
HAE
0001261832
ALLEN PETER M
400 WOOD ROAD
BRAINTREE
MA
02184
0
1
0
0
President, Global Plasma
Common Stock
2014-04-28
4
M
0
30000.0
13.0525
A
58950
D
Common Stock
2014-04-28
4
S
0
30000.0
30.7048
D
28950
D
Non-Qualified Stock Option (right to buy)
13.0525
2014-04-28
4
M
0
30000.0
30.7048
D
2005-05-05
2014-05-05
Common Stock
30000
0
D
Non-Qualified Stock Option (right to buy)
25.535
2008-10-24
2014-10-24
Common Stock
36426
36426
D
Non-Qualified Stock Option (right to buy)
26.47
2010-10-27
2016-10-27
Common Stock
31340
31340
D
Non-Qualified Stock Option (right to buy)
27.275
2009-10-22
2015-10-22
Common Stock
30494
30494
D
Non-Qualified Stock Option (right to buy)
27.495
2011-10-27
2017-10-27
Common Stock
30776
30776
D
Non-Qualified Stock Option (right to buy)
30.67
2012-10-25
2018-10-25
Common Stock
30740
30740
D
Non-Qualified Stock Option (right to buy)
39.055
2013-10-24
2019-10-24
Common Stock
32192
32192
D
Non-Qualified Stock Option (right to buy)
41.66
2014-10-23
2019-10-23
Common Stock
30201
30201
D
Performance Shares
0.0
2017-03-31
2017-12-31
Common Stock
25000
25000
D
Pursuant to a 10b5-1 Plan.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).
By: Alexander Steffan For: Peter Allen
2014-04-29